Healthcare - Biotechnology - NASDAQ - BM
$ 0.4554
5.91 %
$ 1.72 M
Market Cap
0.25
P/E
Price Target
Average
--100.00%
Revenue Forecast
Estimate
-0.00%
EBIT
Estimate
56.96%
Net Income
Estimate
67.71%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Altamira Therapeutics Ltd.
CYTO has no price targets from Wall Street.
REVENUE FORECAST
Revenue Forecast Chart CYTO
EBIT FORECAST
EBIT Forecast Chart CYTO
NET INCOME FORECAST
Net Income Chart CYTO